Carol Scavarda

430 total citations
16 papers, 274 citations indexed

About

Carol Scavarda is a scholar working on Parasitology, Infectious Diseases and Psychiatry and Mental health. According to data from OpenAlex, Carol Scavarda has authored 16 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Parasitology, 10 papers in Infectious Diseases and 6 papers in Psychiatry and Mental health. Recurrent topics in Carol Scavarda's work include Vector-borne infectious diseases (14 papers), Viral Infections and Vectors (9 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (6 papers). Carol Scavarda is often cited by papers focused on Vector-borne infectious diseases (14 papers), Viral Infections and Vectors (9 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (6 papers). Carol Scavarda collaborates with scholars based in United States, China and Mexico. Carol Scavarda's co-authors include Gary P. Wormser, Donna McKenna, John Nowakowski, Robert B. Nadelman, Paul Visintainer, Carol L. Karmen, Rhea Dornbush, Denise R. Cooper, Susan Bittker and Ira Schwartz and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

Carol Scavarda

16 papers receiving 264 citations

Peers

Countries citing papers authored by Carol Scavarda

Since Specialization

Citations

This map shows the geographic impact of Carol Scavarda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol Scavarda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol Scavarda more than expected).

Fields of papers citing papers by Carol Scavarda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol Scavarda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol Scavarda. The network helps show where Carol Scavarda may publish in the future.

Co-authorship network of co-authors of Carol Scavarda

This figure shows the co-authorship network connecting the top 25 collaborators of Carol Scavarda. A scholar is included among the top collaborators of Carol Scavarda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol Scavarda. Carol Scavarda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	A Prospective Study to Characterize Symptoms and Symptom Severity in Adult Patients with Extracutaneous Manifestations of Lyme Disease 2023 ·The American Journal of Medicine ·Gary P. Wormser, Donna McKenna, Tyler R. Morgan, Carol Scavarda, Denise R. Cooper, Paul Visintainer	3
2	Evaluation of selected variables to determine if any had predictive value for, or correlated with, residual symptoms at approximately 12 months after diagnosis and treatment of early Lyme disease 2021 ·Diagnostic Microbiology and Infectious Disease ·Gary P. Wormser, Donna McKenna, (unknown), (unknown), Carol Scavarda, Paul Visintainer	8
3	Patients with Erythema Migrans: Characterizing the Impact of Initiation of Antibiotic Therapy Prior to Study Enrollment 2020 ·Antimicrobial Agents and Chemotherapy ·Gary P. Wormser, Donna McKenna, Eliana Jacobson, (unknown), (unknown), Carol Scavarda, Paul Visintainer	2
4	Prospective Evaluation of the Frequency and Severity of Symptoms in Lyme Disease Patients With Erythema Migrans Compared With Matched Controls at Baseline, 6 Months, and 12 Months 2020 ·Clinical Infectious Diseases ·Gary P. Wormser, Donna McKenna, Carol L. Karmen, (unknown), (unknown), John Nowakowski, Carol Scavarda, Eugene D. Shapiro, Paul Visintainer	23
5	Post-treatment Lyme disease symptoms score: Developing a new tool for research 2019 ·PLoS ONE ·(unknown), Keith Lumbard, (unknown), Carla Williams, Linden T. Hu, Kenneth R. Dardick, Gary P. Wormser, (unknown), Carol Scavarda, Donna McKenna, Dean Follmann, Adriana Marques	11
6	Efficacy of a 14-day course of amoxicillin for patients with erythema migrans 2019 ·Diagnostic Microbiology and Infectious Disease ·Gary P. Wormser, (unknown), (unknown), Carol Scavarda, Donna McKenna	3
7	Measurement of Organ-Specific and Acute-Phase Blood Protein Levels in Early Lyme Disease 2019 ·Journal of Proteome Research ·Yong Zhou, Shizhen Qin, Mingjuan Sun, Li Tang, Xiaowei Yan, (unknown), Juan Caballero-Pérez, Gustavo Glusman, Mary E. Brunkow, Mark J. Soloski, Alison W. Rebman, Carol Scavarda, Denise R. Cooper, Gilbert S. Omenn, Robert L. Moritz, Gary P. Wormser, Nathan D. Price, John N. Aucott, Leroy Hood	12
8	Co-infections in Persons with Early Lyme Disease, New York, USA 2019 ·Emerging infectious diseases ·Gary P. Wormser, Donna McKenna, Carol Scavarda, Denise R. Cooper, (unknown), John Nowakowski, Praveen Sudhindra, (unknown), Guiqing Wang, Carol L. Karmen, Valerie L. Demarest, Alan P. Dupuis, Susan J. Wong	34
9	Evaluation of Prospectively Followed Adult Patients with Erythema Migrans Using the Beck Depression Inventory Second Edition 2018 ·The American Journal of Medicine ·Gary P. Wormser, (unknown), (unknown), (unknown), Donna McKenna, Carol Scavarda, Carol L. Karmen, Rhea Dornbush, Paul Visintainer	7
10	Outcome of facial palsy from Lyme disease in prospectively followed patients who had received corticosteroids 2018 ·Diagnostic Microbiology and Infectious Disease ·Gary P. Wormser, Donna McKenna, Carol Scavarda, Carol L. Karmen	18
11	Assessment of Duration of Tick Feeding by the Scutal Index Reduces Need for Antibiotic Prophylaxis After Ixodes scapularis Tick Bites 2018 ·Clinical Infectious Diseases ·Richard C. Falco, Thomas J. Daniels, (unknown), Donna McKenna, Carol Scavarda, Gary P. Wormser	10
12	Fatigue in patients with erythema migrans 2016 ·Diagnostic Microbiology and Infectious Disease ·Gary P. Wormser, Praveen Sudhindra, (unknown), Lisa Patel, (unknown), (unknown), Donna McKenna, Carol Scavarda, Eugene D. Shapiro, Carol L. Karmen, Paul Visintainer	12
13	Long-term Assessment of Health-Related Quality of Life in Patients With Culture-Confirmed Early Lyme Disease 2015 ·Clinical Infectious Diseases ·Gary P. Wormser, (unknown), Donna McKenna, Robert B. Nadelman, Carol Scavarda, (unknown), Rhea Dornbush, Paul Visintainer, John Nowakowski	30
14	Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease 2015 ·Clinical Infectious Diseases ·(unknown), Donna McKenna, John Nowakowski, Carol Scavarda, Rhea Dornbush, Susan Bittker, Denise R. Cooper, Robert B. Nadelman, Paul Visintainer, Ira Schwartz, Gary P. Wormser	50
15	Long-term Assessment of Fatigue in Patients with Culture-confirmed Lyme Disease 2014 ·The American Journal of Medicine ·Gary P. Wormser, (unknown), Donna McKenna, Robert B. Nadelman, Carol Scavarda, John Nowakowski	30
16	Brief Report: Long‐Term Assessment of Fibromyalgia in Patients With Culture‐Confirmed Lyme Disease 2014 ·Arthritis & Rheumatology ·Gary P. Wormser, (unknown), Donna McKenna, Robert B. Nadelman, Carol Scavarda, (unknown), Priya Prakash, Julia Ash, John Nowakowski	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact